Kody Technolab Limited has appointed Mr. Utsav Himanshu Trivedi as Company Secretary and Compliance Officer effective July 1, 2026. The appointment strengthens the company's corporate governance framework and ensures adherence to statutory and regulatory requirements under the Companies Act and SEBI regulations. The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee.

Mr. Utsav Trivedi is a law graduate and a qualified Company Secretary with an Associate Company Secretary (ACS) membership number 57058. He brings over seven years of professional experience in the areas of corporate laws, securities laws, and finance. His background includes extensive expertise in corporate compliance, secretarial matters, regulatory filings, and corporate governance, with sound knowledge of the Companies Act, SEBI regulations, and other allied laws.

The terms of Mr. Trivedi's appointment are aligned with the recommendations made by the Nomination and Remuneration Committee. His responsibilities will encompass advising on legal and regulatory matters while ensuring strict adherence to applicable statutory and compliance requirements. This strategic move is expected to enhance the company's ability to navigate the complex regulatory landscape effectively.

Key Appointment Details

Kody Technolab Limited has entered into a tripartite agreement with Falcon Tech Robotics LLC and Sscore AI Tech Diagnostic Limited, appointing it as the exclusive worldwide manufacturer of its Medigo range of AI-powered healthcare screening robots. The three-year agreement, effective from June 22, 2026, establishes a commercial framework for the manufacture, supply, distribution, and deployment of these robotic solutions across global markets, targeting a significant unmet need in the healthcare sector.

Agreement Structure and Market Context

Under the agreement, Kody Technolab will manufacture the products on an exclusive worldwide basis, while Falcon Tech Robotics, the company's UAE-based joint venture, will serve as the exclusive global distributor. Sscore AI Tech Diagnostic Limited is responsible for the worldwide deployment and commercialization of the products. Manufacturing and supply of Medigo units are scheduled to commence in H1 of FY 2026-27, supported by a binding minimum purchase framework structured across biannual commercial periods.

The agreement targets the global preventive healthcare market, which industry research projects to grow from approximately USD 268.7 billion in 2023 to USD 585.6 billion by 2030. This expansion addresses the gap where an estimated 4.5 billion people lack full access to essential health services, according to the WHO and World Bank.

The Medigo Product Range

The Medigo range comprises four AI-powered healthcare screening robots designed for clinical-grade preventive screening without dependence on specialized medical staff.

Each unit screens for conditions across metabolic, cardiovascular, infectious, sensory, and mental health categories, generating consolidated reports in the patient’s preferred language and feeding real-time anonymised data into health dashboards.

Strategic Terms and Management Commentary

The agreement includes provisions relating to exclusivity, software support, confidentiality, warranties, intellectual property, and indemnities. It specifies that if Sscore fails to meet minimum purchase commitments, the exclusive manufacturing and supply obligations of Kody and Falcon shall automatically cease, allowing them to engage with third parties. Kody retains the right to continue the agreement on a non-exclusive basis or terminate it upon a 15-day written notice.

Manav Subhashchandra Patel, Managing Director of Kody Technolab Limited, stated that the agreement is a defining moment in the company's journey to scale its healthcare robotics platform globally. Prashant Sawant, Chairman & MD of Sscore AI Tech Diagnostic Limited, highlighted that the Medigo platform offers a uniquely scalable solution to meet critical unmet needs in preventive screening.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE0Q7P01013/ae8100cb241042eb.pdf